[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342484-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342484-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-novel-phosphatase-nudt5-is-a-critical-regulator-of-triple-negative-breast-cancer-growth","The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth","","Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and lacks estrogen receptor, progesterone receptor, and HER2 expression, leaving few effective targeted treatments. This study evaluates NUDT5, a novel phosphatase, as a therapeutic target in TNBC. NUDT5 mRNA was analyzed using TCGA and METABRIC datasets, and in vivo xenograft models tested NUDT5 inhibition. Loss of NUDT5 suppressed TNBC growth by reducing proliferation through oxidative DNA damage and activation of the DNA damage response, supporting future NUDT5 inhibitor development.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-novel-phosphatase-nudt5-is-a-critical-regulator-of-triple-negative-breast-cancer-growth/342484/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-novel-phosphatase-nudt5-is-a-critical-regulator-of-triple-negative-breast-cancer-growth/342484.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is NUDT5’s proposed role in triple-negative breast cancer (TNBC)?","Question",{"text":63,"@type":64},"NUDT5 is investigated as a critical regulator of TNBC growth, particularly through controlling oxidative DNA damage and triggering DNA damage responses when inhibited.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was NUDT5 studied experimentally in the paper?",{"text":68,"@type":64},"The study measured NUDT5 mRNA using TCGA and METABRIC datasets, used siRNA and the small-molecule inhibitor TH5427 for NUDT5 inhibition, and employed TNBC xenograft animal models plus cellular assays.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main effects of losing or inhibiting NUDT5?",{"text":72,"@type":64},"NUDT5 loss or inhibition suppressed TNBC growth in vitro and in vivo. The inhibition increased oxidative DNA lesions such as 8-oxoG and reduced proliferation by interfering with DNA replication.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342484,1790320422,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Qian et al. Breast Cancer Research (2024) 26:23 [https://doi.org/10.1186/s13058-024-01778-w](https://doi.org/10.1186/s13058-024-01778-w)  \nBreast Cancer Research  \n RESEARCH Open Access  \nThe novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth  \nJing Qian1,8, Yanxia Ma1,7, William M. Tahaney 1,2,6, Cassandra L. Moyer 1, Amanda Lanier 1, Jamal Hill 1, Darian Coleman1, Negar Koupaei1,4, Susan G. Hilsenbeck3, Michelle I. Savage 1, Brent D. G. Page5, Abhijit Mazumdar1 and Powel H. Brown 1,2*  \nAbstract  \nBackground The most aggressive form of breast cancer is triple-negative breast cancer (TNBC), which lacks expression of the estrogen receptor (ER) and progesterone receptor (PR), and does not have overexpression of the human epidermal growth factor receptor 2 (HER2) . Treatment options for women with TNBC tumors are limited, unlike those with ER-positive tumors that can be treated with hormone therapy, or those with HER2-positive tumors that can be treated with anti-HER2 therapy. Therefore, we have sought to identify novel targeted therapies forTNBC. In this study, we investigated the potential of a novel phosphatase, NUDT5, as a potential therapeutic target forTNBC.  \nMethods The mRNA expression levels of NUDT5 in breast cancers were investigated using TCGA and METABRIC (Curtis) datasets. NUDT5 ablation was achieved through siRNA targeting and NUDT5 inhibition with the small molecule inhibitor TH5427 . XenograftTNBC animal models were employed to assess the effect of NUDT5 inhibition on in vivo tumor growth. Proliferation, death, and DNA replication assays were conducted to investigate the cellular biological effects of NUDT5 loss or inhibition. The accumulation of 8-oxo-guanine (8-oxoG) and the induction of γH2AX after NUDT5 loss was determined by immunofluorescence staining. The impact of NUDT5 loss on replication fork was assessed by measuring DNA fiber length.  \nResults In this study, we demonstrated the significant role of an overexpressed phosphatase, NUDT5, in regulating oxidative DNA damage inTNBCs. Our findings indicate that loss of NUDT5 results in suppressed growth ofTNBC both in vitro and in vivo. This growth inhibition is not attributed to cell death, but rather to the suppression of proliferation. The loss or inhibition of NUDT5 led to an increase in the oxidative DNA lesion 8-oxoG, and triggered the DNA damage response in the nucleus. The interference with DNA replication ultimately inhibited proliferation. Conclusions NUDT5 plays a crucial role in preventing oxidative DNA damage inTNBC cells. The loss or inhibition of NUDT5 significantly suppresses the growth ofTNBCs. These biological and mechanistic studies provide the groundwork for future research and the potential development of NUDT5 inhibitors as a promising therapeutic approach forTNBC patients.  \nKeywords Phosphatase, Triple-negative breast cancer, Oxidative stress  \n*Correspondence:  \nPowel H. Brown  \n[PHBrown@mdanderson.org](PHBrown@mdanderson.org)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024, corrected publication 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creat","cbCaiujnZXpRIltt","https://ap.wps.com/l/cbCaiujnZXpRIltt","pdf",5916516,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What is NUDT5’s proposed role in triple-negative breast cancer (TNBC)?\",\"answer\":\"NUDT5 is investigated as a critical regulator of TNBC growth, particularly through controlling oxidative DNA damage and triggering DNA damage responses when inhibited.\"},{\"question\":\"How was NUDT5 studied experimentally in the paper?\",\"answer\":\"The study measured NUDT5 mRNA using TCGA and METABRIC datasets, used siRNA and the small-molecule inhibitor TH5427 for NUDT5 inhibition, and employed TNBC xenograft animal models plus cellular assays.\"},{\"question\":\"What were the main effects of losing or inhibiting NUDT5?\",\"answer\":\"NUDT5 loss or inhibition suppressed TNBC growth in vitro and in vivo. The inhibition increased oxidative DNA lesions such as 8-oxoG and reduced proliferation by interfering with DNA replication.\"}]","The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth | PDF",1790046787,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfb42e950589710345b1a75214a71f70.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75b042a8c8b03d23a289fcd96bbf275c.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7384d0804249c89f36ffda4e0647ad2b.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd92f3b11b1081e94208e1137a5d80ec.webp",980,1301]